DBNDD1
Dysbindin domain-containing protein 1
Also known as: DBND1_HUMAN, FLJ12582, MGC3101
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H9R9
- Gene
- DBNDD1
- Ensembl
- ENSG00000003249
- Chromosome
- 16
- Canonical length
- 158 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Cytosol,Equatorial segment,Mid piece,Principal piece,End piece
OverviewNCBI Gene
Predicted to be involved in regulation of signal transduction. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
158 residues, UniProt reviewed canonical sequence.
>Q9H9R9|DBNDD1
1 MEPPEGAGTG EIVKEAEVPQ AALGVPAQGT GDNGHTPVEE EVGGIPVPAP GLLQVTERRQ
61 PLSSVSSLEV HFDLLDLTEL TDMSDQELAE VFADSDDENL NTESPAGLHP LPRAGYLRSP
121 SWTRTRAEQS HEKQPLGDPE RQATVLDTFL TVERPQEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DBNDD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 92 nTPM
- amygdala: 60 nTPM
- skeletal muscle: 47 nTPM
- hippocampal formation: 46 nTPM
- midbrain: 42 nTPM
- cerebellum: 38 nTPM
Single-cell type
- esophageal apical cells: 69 nCPM
- cardiomyocytes: 46 nCPM
- esophageal suprabasal cells: 37 nCPM
- cholangiocytes: 32 nCPM
- breast lactating cells: 23 nCPM
- epicardial cells: 18 nCPM
Immune cell
- naive B-cell: 13 nTPM
- naive CD4 T-cell: 2.9 nTPM
- memory B-cell: 1.2 nTPM
- total PBMC: 1 nTPM
- eosinophil: 0.7 nTPM
- memory CD4 T-cell: 0.6 nTPM
Brain region
- thalamus: 180 nTPM
- cerebral cortex: 111 nTPM
- midbrain: 104 nTPM
- pons: 93 nTPM
- amygdala: 86 nTPM
- hypothalamus: 73 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.53
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DBNDD1 as an antibody target. Whether an autoantibody or antibody against DBNDD1 could matter depends on whether native DBNDD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DBNDD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DBNDD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...